From trialling medicinal cannabis in the treatment of paediatric epilepsy and cancer to a donation that has put Australia at the forefront of medicinal cannabis research, read all the latest news from the Lambert Initiative.
Professor Iain McGregor explains how unlearning has led to a new way of seeing the world - from tennis to the perception of failure.
The University of Sydney and Thomas Jefferson University have officially agreed to collaborate on education and research on the therapeutic uses of cannabinoids.
Australians with epilepsy are turning to cannabis products when antiepileptic drug side-effects are intolerable and epilepsy uncontrolled.
A pioneering study, the Paediatric Epilepsy Lambert Initiative Cannabinoid Analysis (PELICAN), launches today not only to identify issues facing families living with epilepsy but also to analyse cannabis products being used in the community - with the potential to uncover new and more effective medications.
Analysis from the University of Sydney Business School has found that legalising medicinal cannabis in Australia could create a new industry worth more than $100 million per year.
A clinical trial using a new form of cannabis developed by the University of Sydney’s Lambert Initiative will assess the use of the drug to prevent nausea and vomiting in people undergoing chemotherapy.